Anyone with obesity, diabetes, digestive disease, a history of pancreatitis, gallbladder problems, kidney disease, or pregnancy plans should seek medical advice first
A spokesperson for Eli Lilly said that patient safety was a top priority and our medicines labels include robust, FDA-approved warnings. What one researcher has to say David Lau is a professor of biochemistry and molecular biology at the University of Calgary in Alberta, Canada
While nausea is common, not everyone experiences it and its severity varies considerably between individuals
According to this study, both hyperglycemia and hypoglycemia in patients with type 1 diabetes gives rise to endothelial dysfunction, oxidative stress, and inflammation and GLP-1 can be useful to counterbalance these effects
The FDA wants to see actual resolution of liver inflammation and fibrosis improvement, not just fat reduction
"What I often hear is 'my wood is good again' after GLP-associated weight loss."